188 related articles for article (PubMed ID: 35771435)
1. Assessment of Mitochondrial Complex II and III Activity in Brain Sections: A Histoenzymological Technique.
Roy R; Paul R; Bhattacharya P; Borah A
Methods Mol Biol; 2022; 2497():73-81. PubMed ID: 35771435
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease.
Hroudová J; Singh N; Fišar Z
Biomed Res Int; 2014; 2014():175062. PubMed ID: 24900954
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial diseases of the brain.
Chaturvedi RK; Flint Beal M
Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria and neurodegeneration.
Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia.
Schapira AH
Biochim Biophys Acta; 1999 Feb; 1410(2):159-70. PubMed ID: 10076024
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases.
Correia SC; Santos RX; Perry G; Zhu X; Moreira PI; Smith MA
Adv Exp Med Biol; 2012; 724():205-21. PubMed ID: 22411245
[TBL] [Abstract][Full Text] [Related]
7. Neuropathologic features of Parkinson's, Huntington's, and Alzheimer's diseases.
Forno LS
Ann N Y Acad Sci; 1992 May; 648():6-16. PubMed ID: 1386207
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial abnormalities in neurodegenerative models and possible interventions: Focus on Alzheimer's disease, Parkinson's disease, Huntington's disease.
Pantiya P; Thonusin C; Chattipakorn N; Chattipakorn SC
Mitochondrion; 2020 Nov; 55():14-47. PubMed ID: 32828969
[TBL] [Abstract][Full Text] [Related]
9. The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.
Manoharan S; Guillemin GJ; Abiramasundari RS; Essa MM; Akbar M; Akbar MD
Oxid Med Cell Longev; 2016; 2016():8590578. PubMed ID: 28116038
[TBL] [Abstract][Full Text] [Related]
10. The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.
Olesen MA; Villavicencio-Tejo F; Quintanilla RA
Transl Neurodegener; 2022 Jul; 11(1):36. PubMed ID: 35787292
[TBL] [Abstract][Full Text] [Related]
11. Mitophagy in neurodegenerative diseases.
Rodolfo C; Campello S; Cecconi F
Neurochem Int; 2018 Jul; 117():156-166. PubMed ID: 28797885
[TBL] [Abstract][Full Text] [Related]
12. The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects.
Davis MY; Keene CD; Jayadev S; Bird T
J Huntingtons Dis; 2014; 3(2):209-17. PubMed ID: 25062863
[TBL] [Abstract][Full Text] [Related]
13. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease.
Monzio Compagnoni G; Di Fonzo A; Corti S; Comi GP; Bresolin N; Masliah E
Mol Neurobiol; 2020 Jul; 57(7):2959-2980. PubMed ID: 32445085
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
Mantle D; Falkous G; Ishiura S; Perry RH; Perry EK
J Neurol Sci; 1995 Jul; 131(1):65-70. PubMed ID: 7561949
[TBL] [Abstract][Full Text] [Related]
15. The Role of Impaired Mitochondrial Transport in the Development of Neurodegenerative Diseases.
Blagov A; Borisov E; Grechko A; Popov M; Sukhorukov V; Orekhov A
J Integr Neurosci; 2023 Jul; 22(4):86. PubMed ID: 37519177
[TBL] [Abstract][Full Text] [Related]
16. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
Clark LF; Kodadek T
ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
[TBL] [Abstract][Full Text] [Related]
17. Genes and the environment in neurodegeneration.
Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L
Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases.
Chaturvedi RK; Beal MF
Mol Cell Neurosci; 2013 Jul; 55():101-14. PubMed ID: 23220289
[TBL] [Abstract][Full Text] [Related]
19. Role of connexins in neurodegenerative diseases (Review).
Xing J; Xu C
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760195
[TBL] [Abstract][Full Text] [Related]
20. Regional susceptibilities to mitochondrial dysfunctions in the CNS.
Pinto M; Pickrell AM; Moraes CT
Biol Chem; 2012 Apr; 393(4):275-81. PubMed ID: 23029655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]